Bristol-Myers Squibb (BMY) Misses Q4 EPS by 4c; Guides Below the Street

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Bristol-Myers Squibb (BMY) Misses Q4 EPS by 4c; Guides Below the Street

Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Jefferies; Says Takeover 'Increasingly Likely'

January 27, 2017 8:26 AM EST

Jefferies analyst Jeffrey Holford lowered estimates and his price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $69.00) but said a takeover increasingly likely as the stock moves towards our ex-lung valuation of $44.

Holford commented, "Management seems to have scared investors... More

Bristol-Myers Squibb (BMY) Extends Losses Mid-Day

January 26, 2017 12:44 PM EST

Bristol-Myers Squibb (NYSE: BMY) is seeing notable mid-day weakness following results this morning. The company's earnings call has already ended. Shares are down 4.4%.

... More